Lavior Pharma Inc., an International advanced diabetic wound and skincare Company headquartered in Miami, Florida, announced today that they will attend the Florida Podiatric Medical Association’s (FPMA) Annual Summer Conference held June 8-11, 2023, in Bonita Springs, Florida.
Gilad Savion, CEO and Co-Founder of Lavior says, “We are excited to attend the upcoming FPMA’s Annual Summer Conference to share information about our over the counter, all natural, botanical Supercharged Wound Care Hydrogel. The FPMA’s vision to bethe leading voice and pre-eminent resource for the Podiatric Profession in the State of Florida correlates with our vision to be the leading Company that heals diabetic and non-diabetic wounds quicker and less costly than other traditonal treatments. Backed by robust science, we welcome the opportunity to share our vast research, patient outcomes, and introduce Lavior to podatrists and other wound care professionals.”
Over the past 12 years, LAVIOR Pharma Inc. has done extensive research and developed a line of diabetic wound care products based on a well-researched medicinal botanical genus, Inula, and a new species of Inula Viscosa (AGS RIED). This species yields a wide array of sesquiterpenoids, especially sesquiterpene lactones (SLs), as the main secondary metabolites. Two of these SLs, Inuviscolide and Tomentosin, are well known and have been shown to exhibit antimicrobial, antitumor, antiinflammatory, antifungal, and antimalarial activities. Since being introduced to the US, wound care professionals who have introduced Lavior to their patients have seen tremendous results.
About FPMA
First organized in 1927, the FPMA was founded with the aim of enhancing the science of Podiatric Medicine. Committed to increasing knowledge in the field, the FPMA fosters relationships between medical professionals, offering workshops and seminars. Currently, the organization unites more than 1,000 Podiatric Physicians in this common cause.
About Lavior Pharma Inc.
LAVIOR is the only company exclusively dedicated to the therapeutic diabetes skin care market. The LAVIOR skincare product line soothes and heals some of the most widespread and challenging skin problems – diabetic ulcers, wounds, burns, eczema/atopic dermatitis, bacterial and fungal infections, skin irritations, and cracked skin. LAVIOR’s line of products is based on the proven efficacy of the Inula AGS RIED botanical species. They are developed using the highest quality, pharmaceutical grade ingredients; manufactured and tested to deliver safe, effective, and compliant products. Backed by over 13 years of extensive research and clinical trials, proven clinical safety and efficacy, they consistently outperform conventional treatments.
For more information on Lavior Pharma and its products, please visit www.lavior.com
For Media or other Inquiries, please contact:
Anabelle Savion
Chief Marketing Officer
Phone: (+1) 9178373355
